Latest News & Updates
Breaking News
8 minutes ago
Simantini Singh Deo
Other trending news you may like to read
AEON Biopharma Regains NYSE American Listing Compliance After $13.6 Million Public Offering Strengthens Shareholders' Equity
AEON Biopharma regains NYSE American listing compliance after a $13.6 million public offering strengthens its shareholders' equity position.
Simantini Singh Deo
Mobia Medical Appoints Surgeon and Healthcare Executive Dr. Myriam Curet To Board To Support Growth Of Stroke Recovery Business
Mobia Medical appoints surgeon and healthcare executive Dr. Myriam Curet to its Board to support growth of its Vivistim stroke recovery therapy.
Simantini Singh Deo
Codexis Appoints David Butler To Strategic Advisory Board To Support Growth In siRNA Manufacturing And Enzymatic Technologies
Codexis appoints David Butler to its Strategic Advisory Board to support growth in siRNA manufacturing and its enzymatic technology platform.
Simantini Singh Deo
AIM ImmunoTech Completes Final Patient Dosing In Phase 2 DURIPANC Trial Of Ampligen For Metastatic Pancreatic Cancer Ahead Of Schedule
AIM ImmunoTech completes final patient dosing in its Phase 2 DURIPANC trial evaluating Ampligen for metastatic pancreatic cancer, ahead of schedule.
Simantini Singh Deo
